Title : Amplification of DDR2 mediates sorafenib resistance through NF-κB/c-Rel signaling in hepatocellular carcinoma.

Pub. Date : 2021 Sep

PMID : 33969575






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Amplification of DDR2 mediates Sorafenib resistance through NF-kappaB/c-Rel signaling in hepatocellular carcinoma. Sorafenib discoidin domain receptor tyrosine kinase 2 Homo sapiens
2 The effects of DDR2 on Sorafenib resistance were examined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation, TdT-mediated dUTP nick end labeling (TUNEL), and flow cytometry assays. Sorafenib discoidin domain receptor tyrosine kinase 2 Homo sapiens
3 We demonstrated that DDR2 expression was dramatically upregulated in Sorafenib-resistant HCC tissues relative to sensitive tissues. Sorafenib discoidin domain receptor tyrosine kinase 2 Homo sapiens
4 Downregulation of DDR2 sensitized HCC cell lines to Sorafenib cytotoxicity. Sorafenib discoidin domain receptor tyrosine kinase 2 Homo sapiens
5 Our results demonstrated that DDR2 is a potential therapeutic target in patients with HCC, and targeting DDR2 represents a promising approach to increase Sorafenib sensitivity in patients with HCC. Sorafenib discoidin domain receptor tyrosine kinase 2 Homo sapiens